Polmann L, Schliemann C, Sgonina LM, Heptner B, Eisfeld C, Marx J, Mikesch J-H, Reicherts C, Bleckmann A, Lenz G, Stelljes M, Wethmar K. Measurable residual disease-negative remission of BRAF-V600Emutated acute myeloid leukemia with dabrafenib and trametinib. haematol [Internet]. 2020Sep.10 [cited 2026Oct.13];. Available from: https://haematologica.org/article/view/haematol.2026.301553